Beta Bionics, Inc. (BBNX)

NASDAQ

$16.96

$-0.66

(-3.73%)

Regular Market

Beta Bionics, Inc. (BBNX) Live Price Chart

Last updated: ⁦2026-10-14 18:25:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Beta Bionics, Inc. (BBNX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $16.96, with a market capitalisation of $963.48M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.80 to $32.71. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$963.48M
Open	$17.35
Day's High	$32.71
Day's Low	$8.80
Previous Close	$17.69
Volume	501.69K
Average Volume	1.30M
P/E Ratio	--
52-Week High	$32.71
52-Week Low	$8.80
Dividend Yield	--
Earnings Date	--

Beta Bionics, Inc. (BBNX) Stock Price Today

Beta Bionics, Inc. (BBNX) is currently trading at $16.96 as of 2026-10-14 18:23:00, down 4.10% ($0.73) from the previous close of $17.69

During today's regular trading session, BBNX has traded between $8.80 and $32.71, with a trading volume of 501.69K shares. The current price is near the middle of today's range.

Beta Bionics, Inc. (BBNX) 7-Day Stock Price Change

Over the past seven days, Beta Bionics, Inc. (BBNX) moved from $18.95 to $16.96, representing a decline of 10.48% ($1.99).

The stock traded between $16.71 and $19.27 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.03 million shares, down versus the previous seven-day period, indicating lower trading activity.

BBNX 52-Week Price Position

Position in Range: 34.1%

52W Low$8.80

52W High$32.71

BBNX is currently trading at $16.96, placing it 34.1% of the way from its 52-week low of $8.80 to its 52-week high of $32.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Beta Bionics, Inc. (BBNX)?

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Beta Bionics, Inc. Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	423
Exchange	NASDAQ
Company Website	https://www.betabionics.com

How to Buy Beta Bionics, Inc. (BBNX) Stock on MEXC

Eligible investors can buy real shares of Beta Bionics, Inc. (BBNX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BBNX and Place Your Order

Open the RealStocks trading page and search for BBNX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Beta Bionics, Inc. (BBNX) stock price today?

Beta Bionics, Inc. (BBNX) is currently trading at $ 16.96, down 4.10% ($0.73) from the previous close of $ 17.69. Intraday prices update in real time during regular trading hours.

2.Is BBNX stock going up or down today?

As of 2026-10-14 18:23:00, BBNX is trading at $ 16.96, down 4.10% ($0.73) from its previous close of $ 17.69. The stock has traded between $ 8.80 and $ 32.71 during today’s regular session. Past price movements do not guarantee future results.

3.What is BBNX pre-market price?

As of 2026-10-14 18:23:00, BBNX is trading at $ 17.65 in pre-market trading, down 0.22% ($0.04) from the previous close of $ 17.69. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BBNX after-hours price?

As of 2026-10-14 18:23:00, BBNX is trading at $ 17.70 in after-hours trading, up 0.03% ($0.00) from the regular-session close of $ 17.69. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BBNX stock trading now?

BBNX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BBNX sit relative to its 52-week high and low?

Over the past 52 weeks, BBNX has traded between a low of $ 8.80 and a high of $ 32.71. At $ 16.96, the stock is positioned 34.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Beta Bionics, Inc. in?

Beta Bionics, Inc. (BBNX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Beta Bionics, Inc.'s market capitalisation and where is it listed?

Beta Bionics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 963.48M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BBNX valued in terms of P/E ratio and EPS?

BBNX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.35. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Beta Bionics, Inc. pay a dividend?

Beta Bionics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.